Barrington downgraded Cross Country Healthcare (CCRN) to Market Perform from Outperform with an $18.61 price target after the company entered into a definitive agreement to be acquired by Aya Healthcare for $18.61 per share in cash. The new rating assumes that Cross Country shareholders approve the transaction and that no higher competing bids emerge, the analyst tells investors in a research note.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on CCRN:
- Cross Country Healthcare management to meet with Oppenheimer
- Cross Country Healthcare price target raised to $18.61 from $15 at Truist
- Salesforce up after Q3, GM outlines $5B in China business charges: Morning Buzz
- Cross Country Healthcare downgraded to Market Perform at William Blair
- Cross Country Healthcare downgraded to Hold from Buy at Benchmark